Logo image of AG1.DE

AUTO1 GROUP SE (AG1.DE) Stock Fundamental Analysis

FRA:AG1 - Deutsche Boerse Ag - DE000A2LQ884 - Common Stock - Currency: EUR

27.42  +0.06 (+0.22%)

Fundamental Rating

3

AG1 gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 49 industry peers in the Specialty Retail industry. AG1 may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, AG1 is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

AG1 had positive earnings in the past year.
AG1 had negative earnings in 4 of the past 5 years.
In the past 5 years AG1 reported 4 times negative operating cash flow.
AG1.DE Yearly Net Income VS EBIT VS OCF VS FCFAG1.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100M -200M -300M -400M

1.2 Ratios

AG1 has a Return On Assets of 2.33%. This is in the better half of the industry: AG1 outperforms 63.27% of its industry peers.
With a decent Return On Equity value of 8.39%, AG1 is doing good in the industry, outperforming 69.39% of the companies in the same industry.
AG1 has a Return On Invested Capital (4.23%) which is in line with its industry peers.
Industry RankSector Rank
ROA 2.33%
ROE 8.39%
ROIC 4.23%
ROA(3y)-6.82%
ROA(5y)-14.21%
ROE(3y)-17.62%
ROE(5y)-662.11%
ROIC(3y)N/A
ROIC(5y)N/A
AG1.DE Yearly ROA, ROE, ROICAG1.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

1.3 Margins

AG1's Profit Margin of 0.80% is in line compared to the rest of the industry. AG1 outperforms 55.10% of its industry peers.
AG1's Operating Margin of 1.19% is in line compared to the rest of the industry. AG1 outperforms 40.82% of its industry peers.
The Gross Margin of AG1 (11.81%) is worse than 85.71% of its industry peers.
AG1's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 1.19%
PM (TTM) 0.8%
GM 11.81%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.59%
GM growth 5Y3.24%
AG1.DE Yearly Profit, Operating, Gross MarginsAG1.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

More info and screens

3

2. Health

2.1 Basic Checks

AG1 has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, AG1 has more shares outstanding
AG1 has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, AG1 has a worse debt to assets ratio.
AG1.DE Yearly Shares OutstandingAG1.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
AG1.DE Yearly Total Debt VS Total AssetsAG1.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

AG1 has a Debt/Equity ratio of 1.36. This is a high value indicating a heavy dependency on external financing.
AG1's Debt to Equity ratio of 1.36 is on the low side compared to the rest of the industry. AG1 is outperformed by 75.51% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.36
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC0.66
WACC6.42%
AG1.DE Yearly LT Debt VS Equity VS FCFAG1.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M

2.3 Liquidity

A Current Ratio of 2.48 indicates that AG1 has no problem at all paying its short term obligations.
AG1's Current ratio of 2.48 is amongst the best of the industry. AG1 outperforms 89.80% of its industry peers.
AG1 has a Quick Ratio of 1.49. This is a normal value and indicates that AG1 is financially healthy and should not expect problems in meeting its short term obligations.
AG1's Quick ratio of 1.49 is amongst the best of the industry. AG1 outperforms 87.76% of its industry peers.
Industry RankSector Rank
Current Ratio 2.48
Quick Ratio 1.49
AG1.DE Yearly Current Assets VS Current LiabilitesAG1.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 165.71% over the past year.
Looking at the last year, AG1 shows a very strong growth in Revenue. The Revenue has grown by 24.93%.
Measured over the past years, AG1 shows a quite strong growth in Revenue. The Revenue has been growing by 12.53% on average per year.
EPS 1Y (TTM)165.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1500%
Revenue 1Y (TTM)24.93%
Revenue growth 3Y9.52%
Revenue growth 5Y12.53%
Sales Q2Q%33.6%

3.2 Future

AG1 is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 79.09% yearly.
Based on estimates for the next years, AG1 will show a quite strong growth in Revenue. The Revenue will grow by 12.33% on average per year.
EPS Next Y323.75%
EPS Next 2Y167.99%
EPS Next 3Y120.11%
EPS Next 5Y79.09%
Revenue Next Year16.17%
Revenue Next 2Y14.32%
Revenue Next 3Y13.37%
Revenue Next 5Y12.33%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
AG1.DE Yearly Revenue VS EstimatesAG1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B 10B
AG1.DE Yearly EPS VS EstimatesAG1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.5 -0.5 1 -1

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 119.22 indicates a quite expensive valuation of AG1.
AG1's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 27.15. AG1 is valued rather expensively when compared to this.
A Price/Forward Earnings ratio of 47.72 indicates a quite expensive valuation of AG1.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AG1 is on the same level as its industry peers.
AG1 is valuated expensively when we compare the Price/Forward Earnings ratio to 21.60, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 119.22
Fwd PE 47.72
AG1.DE Price Earnings VS Forward Price EarningsAG1.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

AG1's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. AG1 is more expensive than 61.22% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 51.92
AG1.DE Per share dataAG1.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

AG1's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as AG1's earnings are expected to grow with 120.11% in the coming years.
PEG (NY)0.37
PEG (5Y)N/A
EPS Next 2Y167.99%
EPS Next 3Y120.11%

More info and screens

0

5. Dividend

5.1 Amount

AG1 does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AUTO1 GROUP SE

FRA:AG1 (7/1/2025, 9:00:12 AM)

27.42

+0.06 (+0.22%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)05-20 2025-05-20/bmo
Earnings (Next)07-30 2025-07-30
Inst Owners52.64%
Inst Owner ChangeN/A
Ins Owners24.28%
Ins Owner ChangeN/A
Market Cap6.01B
Analysts78.89
Price Target26.03 (-5.07%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)16.06%
Min EPS beat(2)-12.27%
Max EPS beat(2)44.39%
EPS beat(4)3
Avg EPS beat(4)83.53%
Min EPS beat(4)-12.27%
Max EPS beat(4)235.01%
EPS beat(8)6
Avg EPS beat(8)30.59%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)6.18%
Min Revenue beat(2)4.42%
Max Revenue beat(2)7.94%
Revenue beat(4)4
Avg Revenue beat(4)5.9%
Min Revenue beat(4)4.42%
Max Revenue beat(4)7.94%
Revenue beat(8)4
Avg Revenue beat(8)1.35%
Revenue beat(12)7
Avg Revenue beat(12)2.04%
Revenue beat(16)11
Avg Revenue beat(16)3.98%
PT rev (1m)2.83%
PT rev (3m)4.34%
EPS NQ rev (1m)0%
EPS NQ rev (3m)22.86%
EPS NY rev (1m)0%
EPS NY rev (3m)7.6%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)9.39%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.73%
Valuation
Industry RankSector Rank
PE 119.22
Fwd PE 47.72
P/S 0.89
P/FCF N/A
P/OCF N/A
P/B 9.31
P/tB 9.31
EV/EBITDA 51.92
EPS(TTM)0.23
EY0.84%
EPS(NY)0.57
Fwd EY2.1%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS30.83
BVpS2.95
TBVpS2.95
PEG (NY)0.37
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.33%
ROE 8.39%
ROCE 5.08%
ROIC 4.23%
ROICexc 6.81%
ROICexgc 6.81%
OM 1.19%
PM (TTM) 0.8%
GM 11.81%
FCFM N/A
ROA(3y)-6.82%
ROA(5y)-14.21%
ROE(3y)-17.62%
ROE(5y)-662.11%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.59%
GM growth 5Y3.24%
F-ScoreN/A
Asset Turnover2.91
Health
Industry RankSector Rank
Debt/Equity 1.36
Debt/FCF N/A
Debt/EBITDA 7
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.48
Quick Ratio 1.49
Altman-Z N/A
F-ScoreN/A
WACC6.42%
ROIC/WACC0.66
Cap/Depr(3y)56.86%
Cap/Depr(5y)56.61%
Cap/Sales(3y)0.37%
Cap/Sales(5y)0.36%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)165.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1500%
EPS Next Y323.75%
EPS Next 2Y167.99%
EPS Next 3Y120.11%
EPS Next 5Y79.09%
Revenue 1Y (TTM)24.93%
Revenue growth 3Y9.52%
Revenue growth 5Y12.53%
Sales Q2Q%33.6%
Revenue Next Year16.17%
Revenue Next 2Y14.32%
Revenue Next 3Y13.37%
Revenue Next 5Y12.33%
EBIT growth 1Y227.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year318.44%
EBIT Next 3Y99.04%
EBIT Next 5Y74.45%
FCF growth 1Y-220.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-296.41%
OCF growth 3YN/A
OCF growth 5YN/A